Cargando…
Antigen targeting to dendritic cells: Still a place in future immunotherapy?
The hallmark of DCs is their potent and outstanding capacity to activate naive resting T cells. As such, DCs are the sentinels of the immune system and instrumental for the induction of immune responses. This is one of the reasons, why DCs became the focus of immunotherapeutical strategies to fight...
Autores principales: | Stoitzner, Patrizia, Romani, Nikolaus, Rademacher, Christoph, Probst, Hans Christian, Mahnke, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084009/ https://www.ncbi.nlm.nih.gov/pubmed/35598160 http://dx.doi.org/10.1002/eji.202149515 |
Ejemplares similares
-
Antibiotic resistance in the most unlikeliest of places
por: Bartlett, Douglas H.
Publicado: (2017) -
Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors
por: Stoitzner, Patrizia, et al.
Publicado: (2014) -
Murine Langerin(+) dermal dendritic cells prime CD8(+) T cells while Langerhans cells induce cross-tolerance
por: Flacher, Vincent, et al.
Publicado: (2014) -
Murine Langerin(+) dermal dendritic cells prime CD8(+) T cells while Langerhans cells induce cross-tolerance
por: Flacher, Vincent, et al.
Publicado: (2014) -
Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)